Financhill
Back

SPDR® S&P Pharmaceuticals ETF Vs. Invesco Biotechnology & Genome ETF Industry Stock Comparison

Buy
61

XPH
SPDR® S&P Pharmaceuticals ETF

Last Price:
46.59
Seasonality Move:
5.85%
Buy
56

PBE
Invesco Biotechnology & Genome ETF

Last Price:
67.75
Seasonality Move:
5.88%
Buy
61
SPDR® S&P Pharmaceuticals ETF (XPH) is a Buy

Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?

  • The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $46.57. The Score for XPH is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • XPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Invesco Biotechnology & Genome ETF (PBE) is a Buy

Is Invesco Biotechnology & Genome ETF a Buy, Sell or Hold?

  • The current Invesco Biotechnology & Genome ETF [PBE] share price is $69.56. The Score for PBE is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • PBE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XPH Stock Price Chart

What is SPDR® S&P Pharmaceuticals ETF's stock price today?

  • The SPDR® S&P Pharmaceuticals ETF share price today is $46.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XPH is experiencing slight buying pressure.

PBE Stock Price Chart

What is Invesco Biotechnology & Genome ETF's stock price today?

  • The Invesco Biotechnology & Genome ETF share price today is $69.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBE is experiencing buying pressure, which is a positive indicator for future bullish movement.

XPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 53.71 Buy
Chaikin Money Flow: 22026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.57 - 47.27) Buy
Bollinger Bands (100): (42.22 - 46.06) Buy

PBE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 52.57 Buy
Chaikin Money Flow: 7191 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.18 - 70.64) Buy
Bollinger Bands (100): (67.68 - 70.9) Buy

XPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.87 Buy
20-day SMA: 46.46 Buy
50-day SMA: 45.58 Buy
200-day SMA: 42.86 Buy
8-day EMA: 46.11 Buy
20-day EMA: 46.21 Buy
50-day EMA: 45.57 Buy
200-day EMA: 43.29 Buy

PBE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.05 Buy
20-day SMA: 69.21 Buy
50-day SMA: 69.3 Buy
200-day SMA: 66.62 Buy
8-day EMA: 68.49 Buy
20-day EMA: 68.87 Buy
50-day EMA: 69.07 Buy
200-day EMA: 67 Buy

SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Invesco Biotechnology & Genome ETF Earnings Growth & PBE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SPDR® S&P Pharmaceuticals ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Invesco Biotechnology & Genome ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):